Monday, December 11, 2023

❗[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

Breakthrough nerve-sensing technology has the potential to help treat a wide range of disorders

Unsubscribe

email-img


For many, pain can be a constant in life, which is why painkillers are such a huge market – despite typically being a temporary (and sometimes dangerous) "band-aid" solution.

Autonomix has a better idea: Target pain at its source in the nervous system.

Alongside pain management, their breakthrough nerve-sensing technology has the potential to help treat a wide range of disorders including high blood pressure and digestive issues. It's all with one tiny microchip that's intended to target nerve signals at an accuracy never seen before.

The team has 100+ patents issued and pending, and with an estimated total of $100B+ in markets to address, we believe it's a unique opportunity for investors.


See how you can invest in Autonomix before their planned NASDAQ listing.

Disclosure: This is a paid advertisement for Autonomix's Regulation A+ Offering. Please read the offering circular at invest.autonomix.com








 
 
  This email was sent to edwardlorilla1986.paxforex@blogger.com by editor@dailymarketalerts.com

CLM LLC c/o DailyMarketAlerts, 315 Ridgedale Avenue, #556, East Hanover, NJ 07936 United States
 
 

No comments:

Post a Comment

🌎 Summit Materials Upgraded, Integer Initiated, American International Group Downgraded and more...

Ratings changes for Ocugen, A-Mark Precious Metals, Sirius XM, Gladstone Land, Genfit, SuperCom, Daré Bioscience and more... Text "Mark...